Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Emily Singer

A View from Emily Singer

Induced Stem Cells Cure Blood Disease in Mice

The findings demonstrate the cells’ promise in treating disease.

  • December 6, 2007

Scientists have cured a blood disorder in mice using “induced stem cells”–adult skin cells taken from the animals’ tails that were reprogrammed to behave like embryonic stem cells. The findings are the first proof of principle for the potential of these kinds of cells to treat disease.

The cells, known as induced pluripotent cells, have been the source of major excitement among both researchers and the public. They can differentiate into many types of tissue and thus hold promise for cell replacement therapies, but they sidestep the major ethical concern associated with embryonic stem cells: destroying embryos.

In the new experiment, published online today in Science Express, Rudolph Jaenisch and his colleagues at the Whitehead Institute for Biomedical Research, in Cambridge, MA, generated stem cells from the tails of mice with a form of sickle-cell anemia–an inherited blood disorder marked by abnormal blood cells. The researchers then corrected the genetic defect and differentiated the cells into blood-forming stem cells. When injected into mice, the cells developed into healthy blood cells, and the animals’ symptoms began to improve.

Jaenisch and his collaborator George Daley did a similar experiment in 2002 using cloned stem cells. But the new findings show that induced cells can perform the same function, providing a potential mechanism for generating personalized stem cells for tissue-replacement therapies without the ethical and technical hurdles associated with human embryonic stem cells.

Scientists have already taken the first step toward translating the findings to humans. Last month, scientists from Wisconsin and Japan garnered major headlines when they announced that they had created induced cells from human skin cells, bringing the research one step closer to potential treatments. (See “Stem Cells without the Embryos.”) But researchers still face a major hurdle in using these cells in humans: they need to find a safe way to reprogram the cells, which are currently reprogrammed with viruses.

Cut off? Read unlimited articles today.

Become an Insider
Already an Insider? Log in.
More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Plus.
  • Insider Plus {! insider.prices.plus !}*

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    Print + Digital Magazine (6 bi-monthly issues)

    Unlimited online access including all articles, multimedia, and more

    The Download newsletter with top tech stories delivered daily to your inbox

    Technology Review PDF magazine archive, including articles, images, and covers dating back to 1899

    10% Discount to MIT Technology Review events and MIT Press

    Ad-free website experience

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.